Chad R. Heatwole, M.D.

Chad R. Heatwole, M.D.

Contact Information

919 Westfall Rd, Clinton Crossings Bldg C, Suite 220
Rochester, NY 14618

Office: (585) 275-2559
Fax: (585) 273-1255

Journal Articles

Showing all 37 journal articles available.

2016 Feb
Heatwole C, Bode R, Nicholas Johnson , Dekdebrun J, Dilek N, Eichinger K, Hilbert JE, Logigian E, Luebbe E, Martens W, McDermott MP, Pandya S, Puwanant A, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley RT. "Myotonic dystrophy health index: Correlations with clinical tests and patient function." Muscle & nerve. 2016 Feb; 53(2):183-90. Epub 2015 Dec 29.
2015 Aug
Johnson NE, Arnold WD, Hebert D, Gwathmey K, Dimachkie MM, Barohn RJ, McVey AL, Pasnoor M, Amato AA, McDermott MP, Kissel J, Heatwole CR. "Disease course and therapeutic approach in dermatomyositis: A four-center retrospective study of 100 patients." Neuromuscular disorders : NMD. 2015 Aug; 25(8):625-31. Epub 2015 May 07.
2015 Jul
Gagnon C, Meola G, H├ębert LJ, Laberge L, Leone M, Heatwole C. "Report of the second Outcome Measures in Myotonic Dystrophy type 1 (OMMYD-2) international workshop San Sebastian, Spain, October 16, 2013." Neuromuscular disorders : NMD. 2015 Jul; 25(7):603-16. Epub 2015 Jan 27.
2015 May
Sansone VA, Gagnon C, . "207th ENMC Workshop on chronic respiratory insufficiency in myotonic dystrophies: management and implications for research, 27-29 June 2014, Naarden, The Netherlands." Neuromuscular disorders : NMD. 2015 May; 25(5):432-42. Epub 2015 Feb 03.
2015 Mar 10
Bann CM, Abresch RT, Biesecker B, Conway KC, Heatwole C, Peay H, Scal P, Strober J, Uzark K, Wolff J, Margolis M, Blackwell A, Street N, Montesanti A, Bolen J. "Measuring quality of life in muscular dystrophy." Neurology. 2015 Mar 10; 84(10):1034-42. Epub 2015 Feb 06.
2014 Nov
Johnson NE, Heatwole CR, Dilek N, Sowden J, Kirk CA, Shereff D, Shy ME, Herrmann DN, . "Quality-of-life in Charcot-Marie-Tooth disease: the patient's perspective." Neuromuscular disorders : NMD. 2014 Nov; 24(11):1018-23. Epub 2014 Jun 27.
2014 Oct
Bushby K, Finkel R, Wong B, Barohn R, Campbell C, Comi GP, Connolly AM, Day JW, Flanigan KM, Goemans N, Jones KJ, Mercuri E, Quinlivan R, Renfroe JB, Russman B, Ryan MM, Tulinius M, Voit T, Moore SA, Lee Sweeney H, Abresch RT, Coleman KL, Eagle M, Florence J, Gappmaier E, Glanzman AM, Henricson E, Barth J, Elfring GL, Reha A, Spiegel RJ, O'donnell MW, Peltz SW, Mcdonald CM, . "Ataluren treatment of patients with nonsense mutation dystrophinopathy." Muscle & nerve. 2014 Oct; 50(4):477-87.
2014 Jul
Johnson NE, Luebbe E, Eastwood E, Chin N, Moxley RT, Heatwole CR. "The impact of congenital and childhood myotonic dystrophy on quality of life: a qualitative study of associated symptoms." Journal of child neurology. 2014 Jul; 29(7):983-6. Epub 2013 Apr 22.
2014 Jun
Heatwole C, Bode R, Johnson N, Dekdebrun J, Dilek N, Heatwole M, Hilbert JE, Luebbe E, Martens W, McDermott MP, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley R. "Myotonic Dystrophy Health Index: initial evaluation of a disease-specific outcome measure." Muscle & nerve. 2014 Jun; 49(6):906-14.
2013 Sep
Johnson NE, Heatwole CR, Ferguson M, Sowden JE, Jeanat S, Herrmann DN. "Patient identification of the symptomatic impact of charcot-marie-tooth disease type 1A." Journal of clinical neuromuscular disease. 2013 Sep; 15(1):19-23.
2013 Jun 11
Johnson NE, Heatwole CR. "Teaching video neuroimages: trapezius myotonia percussion sign in myotonic dystrophy type 2." Neurology. 2013 Jun 11; 80(24):e251.
2013 May
Heatwole CR, Statland JM, Logigian EL. "The diagnosis and treatment of myotonic disorders." Muscle & nerve. 2013 May; 47(5):632-48. Epub 2013 Mar 27.
2013 Apr
Statland JM, McDermott MP, Heatwole C, Martens WB, Pandya S, van der Kooi EL, Kissel JT, Wagner KR, Tawil R. "Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy." Neuromuscular disorders : NMD. 2013 Apr; 23(4):306-12. Epub 2013 Feb 11.
2013 Jan 15
Genovese DW, Estrada AH, Maisenbacher HW, Heatwole BA, Powell MA. "Procedure times, complication rates, and survival times associated with single-chamber versus dual-chamber pacemaker implantation in dogs with clinical signs of bradyarrhythmia: 54 cases (2004-2009)." Journal of the American Veterinary Medical Association. 2013 Jan 15; 242(2):230-6.
Nakamori M, Sobczak K, Puwanant A, Welle S, Eichinger K, Pandya S, Dekdebrun J, Heatwole CR, McDermott MP, Chen T, Cline M, Tawil R, Osborne RJ, Wheeler TM, Swanson M, Moxley RT, Thornton CA. "Splicing biomarkers of disease severity in myotonic dystrophy." Annals of neurology. 2013 74(6):862-72.
2012 Jul 24
Heatwole C, Bode R, Johnson N, Quinn C, Martens W, McDermott MP, Rothrock N, Thornton C, Vickrey B, Victorson D, Moxley R. "Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1)." Neurology. 2012 Jul 24; 79(4):348-57. Epub 2012 Jul 11.
2012 Jul
Johnson NE, Heatwole CR. "Myotonic dystrophy: from bench to bedside." Seminars in neurology. 2012 Jul; 32(3):246-54. Epub 2012 Nov 01.
Johnson NE, Quinn C, Eastwood E, Tawil R, Heatwole CR. "Patient-identified disease burden in facioscapulohumeral muscular dystrophy." Muscle & nerve. 2012 46(6):951-3.
2011 Sep
Heatwole C, Johnson N, Goldberg B, Martens W, Moxley R. "Laboratory abnormalities in patients with myotonic dystrophy type 2." Archives of neurology. 2011 Sep; 68(9):1180-4.
2011 Jan
Heatwole CR, Eichinger KJ, Friedman DI, Hilbert JE, Jackson CE, Logigian EL, Martens WB, McDermott MP, Pandya SK, Quinn C, Smirnow AM, Thornton CA, Moxley RT. "Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1." Archives of neurology. 2011 Jan; 68(1):37-44. Epub 2010 Sep 13.
Chad R. Heatwole, MD, MS-CI; Katy J. Eichinger, PT, DPT, NCS; Deborah I. Friedman, MD, MPH; James E. Hilbert, MS; Carlayne E. Jackson, MD; Eric L. Logigian, MD; William B. Martens, BA; Michael P. McDermott, PhD; Shree K. Pandya, PT, MS; Christine Quinn, MS; Alexis M. Smirnow, BS; Charles A. Thornton, MD; Richard T. Moxley III, MD. "An Open-Label Trial of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-1/rhIGFBP-3) in Myotonic Dystrophy Type 1." Archives of Neurology. 2011; 68(1): 37-44.
Heatwole C, Johnson N, Holloway R, Noyes K. "Plasma exchange versus intravenous immunoglobulin for myasthenia gravis crisis: an acute hospital cost comparison study." Journal of clinical neuromuscular disease. 2011 13(2):85-94.
2010 Feb
Logigian EL, Twydell P, Dilek N, Martens WB, Quinn C, Wiegner AW, Heatwole CR, Thornton CA, Moxley RT. "Evoked myotonia can be "dialed-up" by increasing stimulus train length in myotonic dystrophy type 1." Muscle & nerve. 2010 Feb; 41(2):191-6.
Logigian, EL; Twydell, P; Dilek, N; Martens, WB; Quinn, C; Wiegner, AW; Heatwole, CR; Thornton, CA, Moxley, RT 3rd. "Evoked Myotonia Can be "Dialed-Up" by Increasing Stimulus Train Length in Myotonic Dystrophy Type-1." Muscle Nerve. 2009 Sep 11. Epub ahead of print. 2009; .
Chad R. Heatwole, MD; Richard T. Moxley III, MD. "Pharmacologic Treatment of Neuromuscular Disease. Principles of Drug Therapy in Neurology." Editors: Michael Johnston, Robert Gross, Sid Gilman. New York:. 2008; : 292-343.
Heatwole C, Ciafaloni E. "Mycophenolate mofetil for myasthenia gravis: a clear and present controversy." Neuropsychiatric disease and treatment. 2008 4(6):1203-9.
2007 Oct 23
Heatwole C. "International Education Issues: practicing and teaching international neurology: the Krakow experience." Neurology. 2007 Oct 23; 69(17):1721-3.
2007 Apr
Heatwole CR, Moxley RT. "The nondystrophic myotonias." Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2007 Apr; 4(2):238-51.
Chad R. Heatwole, MD; Craig M. Heatwole, Ph.D.; Eric E. Heatwole, MD; Eric E. Potts, MD. "Minimizing the spread of Infectious Disease Through Lavatory Design." Engineering Design and Construction. 2007; 6.
Chad R. Heatwole, MD; Craig M. Heatwole, PhD.; Eric E. Heatwole, MD; eric E. Potts, MD. "Minimizing the Spread of Infectious Disease Through Lavatory Design: The Implementation of the Heatwole-Potts Lavatory Scale." Engineering Design and Construction Magazine Archived Article. 2007; .
Chad R. Heatwole, MD; Richard T. Moxley, III, MD. "Proposed Mechanisms of Acetazolamide in Chloride Channelopathies." Journal Watch Neurology. 2007; .
2006 Aug
Heatwole CR, Miller J, Martens B, Moxley RT. "Laboratory abnormalities in ambulatory patients with myotonic dystrophy type 1." Archives of neurology. 2006 Aug; 63(8):1149-53.
Heatwole, C; Moxley, R. "Myotonic Dystrophy. An update". Medlink. 2006; .
2005 Mar 22
Heatwole CR, Berg MJ, Henry JC, Hallman JL. "Extreme spindles: a distinctive EEG pattern in Mycoplasma pneumoniae encephalitis." Neurology. 2005 Mar 22; 64(6):1096-7.
2005 Feb
Heatwole, C; Moxley, R. "Myotonic Dystrophy". Medlink. 2005; .
Heatwole, C. "Land of Beauty and Hardship: SET in Nepal. The Mennonite Health Journal". The Mennonite Health Journal. 2005; 7(3).
Heatwole, C. "SET Training in the Land of Mt. Everest". Mennonite Health Journal. 2002; 4(1).


Johnson, N; Heatwole, C. "Myotonic Dystrophies". Neuromuscular Disorders. : Blackwell Publishing Ltd, 2011.
C.R. Heatwole. The Corridor. : James A Rock & Co. Publishers, 2009.
Chad R. Heatwole, MD; Richard T. Moxley III, MD. "Pharmacologic Treatment of Neuromuscular Disease.". Principles of Drug Therapy in Neurology. Michael Johnston, Robert Gross, Sid Gilman. : F.A. Davis, 2008. 630-758